Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 4 Study of the Pharmacokinetics of Oral Posaconazole (SCH 56592) Among Patients With Compromised Gastrointestinal Function and at High Risk for Invasive Fungal Infection

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00686543
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:36:37.352238+00:00
Published At
2010-05-14T00:00:00+00:00
Record Updated At
2017-04-07
Results Posted At
2010-05-14
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Fungal Infection", "Acute Myelogenous Leukemia", "Neutropenia"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-04-07"
protocolSection.identificationModule.nctId
"NCT00686543"
protocolSection.identificationModule.officialTitle
"A Phase 4 Study of the Pharmacokinetics of Oral Posaconazole (SCH 56592) Among Patients With Compromised Gastrointestinal Function and at High Risk for Invasive Fungal Infection"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2010-05-14"

Study condition terms

  • Fungal Infection (protocolSection.conditionsModule.conditions)
  • Acute Myelogenous Leukemia (protocolSection.conditionsModule.conditions)
  • Neutropenia (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.